Antibacterial diterpenes from Plectranthus ernstii.

Area of Science:

• Natural Products Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Plectranthus ernstii is a plant species known for its potential medicinal properties.
• Diterpenoids are a class of natural compounds with diverse biological activities.
• Investigating novel compounds from natural sources is crucial for drug discovery.

Purpose of the Study:

• To isolate and characterize new diterpenoids from Plectranthus ernstii.
• To evaluate the antimicrobial and antimycobacterial activities of the isolated compounds.

Main Methods:

• Isolation and purification of compounds using chromatographic techniques.
• Structure elucidation using spectroscopic methods, including single-crystal X-ray structural analysis.
• Antimicrobial and antimycobacterial activity assays to determine minimum inhibitory concentrations (MIC).

Main Results:

• Three new diterpenoids, two pimaranes (1 and 2) and one labdane (3), were successfully isolated and characterized.
• Compound 1 demonstrated moderate antistaphylococcal activity against multidrug-resistant (MDR) and methicillin-resistant Staphylococcus aureus (MRSA) strains (MIC = 32 microg/mL).
• All three isolated diterpenoids exhibited antimycobacterial activity against rapidly growing mycobacteria strains (MICs ranging from 8 to 128 microg/mL).

Conclusions:

• Plectranthus ernstii is a source of novel diterpenoids with significant antimicrobial and antimycobacterial potential.
• The isolated compounds, particularly compound 1, show promise for further development against resistant bacterial infections.
• These findings contribute to the understanding of Plectranthus ernstii phytochemistry and its therapeutic applications.